Symbiosis Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 3.96 Cr
- Company Age 21 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 61.07 Cr
- Satisfied Charges ₹ 12.37 Cr
- Revenue Growth 21.86%
- Profit Growth 1.60%
- Ebitda -9.63%
- Net Worth 7.29%
- Total Assets 16.48%
About Symbiosis Pharmaceuticals
Symbiosis Pharmaceuticals Private Limited (SPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 04 April 2003 and has a history of 21 years and nine months. Its registered office is in Ambala, Haryana, India.
The Corporate was formerly known as Symbiosis Pharmaceutical Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 3.96 Cr.
The company currently has active open charges totaling ₹61.07 Cr. The company has closed loans amounting to ₹12.37 Cr, as per Ministry of Corporate Affairs (MCA) records.
Company Details
-
Location
Ambala, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239HR2003PTC035085
-
Company No.
035085
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Apr 2003
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Symbiosis Pharmaceuticals Private Limited offer?
Symbiosis Pharmaceuticals Private Limited offers a wide range of products and services, including Beams, Purlins, Frames and Girders, Purlin, Antibiotic Tablets & Capsules, Cefixime Tablet, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Dietary Supplements, Common Disease Medicines, Oral Care Products.
Who are the key members and board of directors at Symbiosis Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagbir Singh
|
Director | 04-Apr-2003 | Current |
|
Vishwambhar Gupta
|
Director | 20-Nov-2008 | Current |
|
Sheetal Dass
|
Director | 30-Jun-2007 | Current |
|
Harnek Singh
|
Director | 12-Apr-2021 | Current |
Financial Performance of Symbiosis Pharmaceuticals.
Symbiosis Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 21.86% increase. The company also saw a slight improvement in profitability, with a 1.6% increase in profit. The company's net worth moved up by a moderate rise of 7.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Symbiosis Pharmaceuticals?
In 2022, Symbiosis Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Prism Medico And Pharmacy LimitedVishwambhar Gupta is a mutual person
-
Sai Tech Medicare Private Limited
Vishwambhar Gupta, Jagbir Singh and 1 more are mutual person
-
Symbiosis Life Sciences Limited
Vishwambhar Gupta and Jagbir Singh are mutual person
-
Lifekyor Overseas Private Limited
Jagbir Singh is a mutual person
-
Laxter Pharmaceuticals Private Limited
Jagbir Singh is a mutual person
Charges (Loans)
₹61.07 Cr
₹12.37 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 60.24 Cr
- General Manager : 0.30 Cr
- Hdfc Bank Limited : 0.28 Cr
- Others : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Oct 2023 | Hdfc Bank Limited | ₹2.78 M | Open |
| 09 May 2022 | State Bank Of India | ₹2.06 Cr | Open |
| 27 Oct 2020 | State Bank Of India | ₹1.66 Cr | Open |
| 28 Aug 2020 | State Bank Of India | ₹2.36 Cr | Open |
| 16 May 2020 | State Bank Of India | ₹2.10 Cr | Open |
How Many Employees Work at Symbiosis Pharmaceuticals?
Symbiosis Pharmaceuticals has a workforce of 47 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Symbiosis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Symbiosis Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
